Trial · NCT02726620
Outcomes46
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 46
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Postoperative Acute Kidney Injury | Within 7 days after surgery | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | 30-day Mortality | 30 days after surgery | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). For a large group of patients no mortality information was available. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | In-hospital Mortality | All postoperative days during a single hospital admission, expected median of 5 days | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Postoperative Acute Kidney Injury Stage 2 | Within 7 days after surgery | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Postoperative Rise in Creatinine Levels | Within 7 days after surgery | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). Patients with no routine postoperative creatinine measurements are excluded from the analysis. | mg/dL | MEDIAN |
| SECONDARY | Incidence of a MAP < 60 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 55 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 50 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 60 mmHg for > 10 Minutes | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 55 mmHg for > 10 Minutes | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 50 mmHg for > 10 Minutes | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 60 mmHg for > 20 Minutes | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 55 mmHg for > 20 Minutes | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incidence of a MAP < 50 mmHg for > 20 Minutes | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Depth and Duration of Intraoperative Hypotension - Threshold MAP 75 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | mmHg*minute | MEDIAN |
| SECONDARY | Depth and Duration of Intraoperative Hypotension - Threshold MAP 70 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | mmHg*minute | MEDIAN |
| SECONDARY | Depth and Duration of Intraoperative Hypotension - Threshold MAP 65 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | mmHg*minute | MEDIAN |
| SECONDARY | Depth and Duration of Intraoperative Hypotension - Threshold MAP 60 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | mmHg*minute | MEDIAN |
| SECONDARY | Depth and Duration of Intraoperative Hypotension - Threshold MAP 55 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | mmHg*minute | MEDIAN |
| SECONDARY | Depth and Duration of Intraoperative Hypotension - Threshold MAP 50 mmHg | During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours | Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis (See also 'Participant Flow' section). | mmHg*minute | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02726620/outcomes